Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway
Breast cancer is the most common cancer worldwide. A number of studies proposed that long non-coding RNA plays an essential role in the regulation of invasion and metastasis of various forms of malignancy, including lung cancer, gastric cancer, and bladder cancer. In this study, a long non-coding RN...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2022
|
Online Access: | View Fulltext in Publisher |
LEADER | 01797nam a2200205Ia 4500 | ||
---|---|---|---|
001 | 10.1038-s41420-022-01043-z | ||
008 | 220706s2022 CNT 000 0 und d | ||
020 | |a 20587716 (ISSN) | ||
245 | 1 | 0 | |a Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway |
260 | 0 | |b Springer Nature |c 2022 | |
856 | |z View Fulltext in Publisher |u https://doi.org/10.1038/s41420-022-01043-z | ||
520 | 3 | |a Breast cancer is the most common cancer worldwide. A number of studies proposed that long non-coding RNA plays an essential role in the regulation of invasion and metastasis of various forms of malignancy, including lung cancer, gastric cancer, and bladder cancer. In this study, a long non-coding RNA(LncRNA) MAFG-AS1 was explored in detail to understand the significance in the etiology of breast cancer. The results indicated that expression of LncRNA MAFG-AS1 in the breast cancer tissues was significantly higher than the adjacent normal breast tissues and elevated expression level of LncRNA MAFG-AS1 was correlated to the larger tumor size, negative expression of ER, PR and lymph node metastasis. The potency of breast cancer proliferation, invasion, and metastasis was inhibited in the absence of LncRNA MAFG-AS1. Mechanically, LncRNA MAFG-AS1 was mainly located in the cytoplasm. The downstream target gene of LncRNA MAFG-AS1 was STC2 which might promote cell proliferation and metastasis in breast cancer and this study provides a new potential therapeutic target for breast cancer. © 2022, The Author(s). | |
700 | 1 | 0 | |a Bai, R. |e author |
700 | 1 | 0 | |a Chen, C. |e author |
700 | 1 | 0 | |a Di, S. |e author |
700 | 1 | 0 | |a Lu, D. |e author |
700 | 1 | 0 | |a Ma, T. |e author |
700 | 1 | 0 | |a Zhang, Z. |e author |
700 | 1 | 0 | |a Zou, Z. |e author |
773 | |t Cell Death Discovery |